Cargando…

Involvement of hepcidin in iron metabolism dysregulation in Gaucher disease

Gaucher disease (GD) is an inherited deficiency of glucocerebrosidase leading to accumulation of glucosylceramide in tissues such as the spleen, liver, and bone marrow. The resulting lipid-laden macrophages lead to the appearance of “Gaucher cells”. Anemia associated with an unexplained hyperferriti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lefebvre, Thibaud, Reihani, Niloofar, Daher, Raed, de Villemeur, Thierry Billette, Belmatoug, Nadia, Rose, Christian, Colin-Aronovicz, Yves, Puy, Hervé, Le Van Kim, Caroline, Franco, Mélanie, Karim, Zoubida
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ferrata Storti Foundation 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865418/ https://www.ncbi.nlm.nih.gov/pubmed/29305416 http://dx.doi.org/10.3324/haematol.2017.177816

Ejemplares similares

Extrahepatic hepcidin production: The intriguing outcomes of recent years
por: Daher, Raêd, et al.
Publicado: (2019)

Type 3 Gaucher disease, diagnostic in adulthood
por: Detollenaere, Charles, et al.
Publicado: (2017)

Crosstalk between Acidosis and Iron Metabolism: Data from In Vivo Studies
por: Daher, Raêd, et al.
Publicado: (2022)

Effects of sphingolipids overload on red blood cell properties in Gaucher disease
por: Dupuis, Lucie, et al.
Publicado: (2020)

A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments
por: Stirnemann, Jérôme, et al.
Publicado: (2017)

Kinetics of serum hepcidin and interleukin-6 levels following COVID-19 infection in hemodialysis patients
por: Touzot, Maxime, et al.
Publicado: (2021)

Hepcidin and Iron Deficiency in Women One Year after Sleeve Gastrectomy: A Prospective Cohort Study
por: Lefebvre, Thibaud, et al.
Publicado: (2021)

Immunoglobulin Abnormalities in Gaucher Disease: an Analysis of 278 Patients Included in the French Gaucher Disease Registry
por: Nguyen, Yann, et al.
Publicado: (2020)

Oculomotor and Vestibular Findings in Gaucher Disease Type 3 and Their Correlation with Neurological Findings
por: Bremova-Ertl, Tatiana, et al.
Publicado: (2018)

Iron deficiency diagnosed using hepcidin on critical care discharge is an independent risk factor for death and poor quality of life at one year: an observational prospective study on 1161 patients
por: Lasocki, Sigismond, et al.
Publicado: (2018)

The French Gaucher’s disease registry: clinical characteristics, complications and treatment of 562 patients
por: Stirnemann, Jérôme, et al.
Publicado: (2012)

Phagocytosis of Erythrocytes from Gaucher Patients Induces Phenotypic Modifications in Macrophages, Driving Them toward Gaucher Cells
por: Dupuis, Lucie, et al.
Publicado: (2022)

A Cross-Sectional Retrospective Study of Non-Splenectomized and Never-Treated Patients with Type 1 Gaucher Disease
por: Serratrice, Christine, et al.
Publicado: (2020)

Impact of imiglucerase supply constraint on the therapeutic management and course of disease in French patients with Gaucher disease type 1
por: Stirnemann, Jérôme, et al.
Publicado: (2015)

Bone events and evolution of biologic markers in Gaucher disease before and during treatment
por: Stirnemann, Jérôme, et al.
Publicado: (2010)

Demographics and patient characteristics of 1209 patients with Gaucher disease: Descriptive analysis from the Gaucher Outcome Survey (GOS)
por: Zimran, Ari, et al.
Publicado: (2017)

Gaucher Disease in Bone: From Pathophysiology to Practice
por: Hughes, Derralynn, et al.
Publicado: (2019)

Dyserythropoiesis evaluated by the RED score and hepcidin:ferritin ratio predicts response to erythropoietin in lower-risk myelodysplastic syndromes
por: Park, Sophie, et al.
Publicado: (2019)

Early detection of median nerve compression by Electroneurography can improve outcome in children with Mucopolysaccharidoses
por: Maincent, Kim, et al.
Publicado: (2018)

Dysregulated hepcidin response to dietary iron in male mice with reduced Gnpat expression
por: Rishi, Gautam, et al.
Publicado: (2020)

Modeling changes in biomarkers in Gaucher disease patients receiving enzyme replacement therapy using a pathophysiological model
por: Vigan, Marie, et al.
Publicado: (2014)

The Relevancy of Data Regarding the Metabolism of Iron to Our Understanding of Deregulated Mechanisms in ALS; Hypotheses and Pitfalls
por: Petillon, Camille, et al.
Publicado: (2019)

Iron, Heme Synthesis and Erythropoietic Porphyrias: A Complex Interplay
por: Poli, Antoine, et al.
Publicado: (2021)

Porphyria and kidney diseases
por: Pallet, Nicolas, et al.
Publicado: (2018)

Hepcidin suppression and defective iron recycling account for dysregulation of iron homeostasis in heme oxygenase-1 deficiency
por: Kartikasari, Apriliana E R, et al.
Publicado: (2010)

Hepcidin suppression and defective iron recycling account for dysregulation of iron homeostasis in heme oxygenase-1 deficiency
por: Kartikasari, Apriliana E R, et al.
Publicado: (2009)

Splenic Artery Aneurysms, a Rare Complication of Type 1 Gaucher Disease: Report of Five Cases
por: Serratrice, Christine, et al.
Publicado: (2019)

Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome
por: de Montalembert, Mariane, et al.
Publicado: (2017)

Hepatocellular carcinoma in Gaucher disease: an international case series
por: Regenboog, Martine, et al.
Publicado: (2018)

Hygiene promotion might be better than serological screening to deal with Cytomegalovirus infection during pregnancy: a methodological appraisal and decision analysis
por: Billette de Villemeur, Agathe, et al.
Publicado: (2020)

COVID-19 and iron dysregulation: distant sequence similarity between hepcidin and the novel coronavirus spike glycoprotein
por: Ehsani, Sepehr
Publicado: (2020)

Presenting signs and patient co‐variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED‐C) Delphi initiative
por: Mehta, Atul, et al.
Publicado: (2019)

Pregnancy outcome in women with Gaucher disease type 1 who had unplanned pregnancies during eliglustat clinical trials
por: Lukina, Elena, et al.
Publicado: (2020)

Quality of life in patients with locked-in syndrome: Evolution over a 6-year period
por: Rousseau, Marie-Christine, et al.
Publicado: (2015)

Gaucher Disease and Gaucher Cells
por: Gözdaşoğlu, Sevgi
Publicado: (2015)

Iron, anemia and hepcidin in malaria
por: Spottiswoode, Natasha, et al.
Publicado: (2014)

Iron, hepcidin, and the metal connection
por: Loréal, Olivier, et al.
Publicado: (2014)

Hepcidin and Iron in Health and Disease
por: Nemeth, Elizabeta, et al.
Publicado: (2023)

Salmonella effector SpvB aggravates dysregulation of systemic iron metabolism via modulating the hepcidin−ferroportin axis
por: Deng, Qifeng, et al.
Publicado: (2021)

A Prospective Study of Bone Marrow Hematopoietic and Mesenchymal Stem Cells in Type 1 Gaucher Disease Patients
por: Lecourt, Séverine, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_l71f1kuhvsjbehbjoid19ag6mt